Skip To Main Content
C Ortega on Muck Rack

C Ortega

As seen in: European Journal of Hospital Pharmacy, Dialnet - Universidad de La Rioja
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to C Ortega’s profile

Articles by C Ortega

Valores de referencia de HOMA-IR y QUICKI durante el embarazo en mujeres mexicanas

|
By Enrique Reyes-Muñoz, C Ortega, EM Martínez-Herrera, L Arce-Sánchez
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Valores de referencia de HOMA-IR y QUICKI durante el embarazo en mujeres mexicanas Autores: Enrique Reyes-Muñoz, EM Martínez-Herrera, C Ortega, L Arce-Sánchez, A Ávila-Carrasco, Rodrigo Zamora Escudero Localización: Ginecología y Obstetricia de México, ISSN 0300-9041, ISSN-e 2594-2034, Vol. 85, Nº. 5, 2017, págs. 306-313 Idioma: español Títulos paralelos: HOMA-IR and QUICKI reference values during pregnancy in Mexican women.
Open in Who Shared Issue with article?

Resultados périnatales en embarazos múltiples monocoriales relacionados con las características placentarias

|
By Saulo Molina Giraldo, C Ortega, AF Solano-Montero, NL Santana-Corredor
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Resultados périnatales en embarazos múltiples monocoriales relacionados con las características placentarias Autores: Saulo Molina Giraldo, AF Solano-Montero, NL Santana-Corredor, C Ortega, DA Alfonso-Ayala Localización: Ginecología y Obstetricia de México, ISSN 0300-9041, ISSN-e 2594-2034, Vol. 85, Nº. 2, 2017, págs.
Open in Who Shared Issue with article?

CP-006 Ketoconazole and performance status as predictive factors of response to abiraterone in metastasic prostate cancer in real life conditions

|
By A Ribed, M Tovar, V Escudero, C Ortega
| European Journal of Hospital Pharmacy Verified
Background Abiraterone is an oral antiandrogen therapy approved in September 2011 by the European Medicines Agency (EMA) for metastatic castration resistant prostate cancer (mCRPC) in men whose disease had progressed on a docetaxel based chemotherapy, and was included in our hospital´s formulary in 2012.
Open in Who Shared Issue with article?
Show More